COMMUNICATION
Superoxide in Apoptosis
MITOCHONDRIAL GENERATION TRIGGERED BY CYTOCHROME c LOSS*

Jiyang Cai and Dean P. JonesDagger

From the Department of Biochemistry, Emory University School of Medicine, Atlanta, Georgia 30322

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results & Discussion
References

Activation of apoptosis is associated with generation of reactive oxygen species. The present research shows that superoxide is produced by mitochondria isolated from apoptotic cells due to a switch from the normal 4-electron reduction of O2 to a 1-electron reduction when cytochrome c is released from mitochondria. Bcl-2, a protein that protects against apoptosis and blocks cytochrome c release, prevents superoxide production when it is overexpressed. The switch in electron transfer provides a mechanism for redox signaling that is concomitant with cytochrome c-dependent activation of caspases. The block of cytochrome c release provides a mechanism for the apparent antioxidant function of Bcl-2.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results & Discussion
References

Reactive oxygen species (ROS)1 are important regulators of apoptosis. Pro-oxidants and redox cycling agents, such as H2O2 (1), diamide (2), etoposide (3), and semiquinones (4), can induce apoptosis. Other apoptotic stimuli, such as treatment with TNFalpha (5), lipopolysaccharide (6), ceramide (7), growth factor withdrawal (8), and human immunodeficiency virus infection (9), can stimulate the ROS production. Studies with TNFalpha and ceramide have shown that these agents activated ROS generation by mitochondria (7). The recent proposed model of p53-induced apoptosis also placed ROS as a central signaling event (10, 11). Antioxidants and thiol reductants, such as NAC (12), overexpression of thioredoxin (13), and MnSOD (14), can block or delay apoptosis. On the other hand, ROS can provide protective mechanisms under some conditions, such as the activation of NFkappa B by TNF-induced ROS production (15, 16). Thus ROS, and the resulting cellular redox change, can be part of the signal transduction pathway during apoptosis. Yet the mechanisms of ROS generation and its relationship with the well studied caspase activation have not been resolved.

A role of ROS during apoptosis was initially proposed based upon the observation that Bcl-2, a general inhibitor of apoptosis in mammalian cells, has an apparent antioxidant function (17, 18). Bcl-2 is largely localized to the mitochondrial outer membrane, and when overexpressed, it protects cells from lipid peroxidation and thiol oxidation induced by menadione and hydrogen peroxide (17, 18). Bcl-2 also protects rho 0 cells from apoptosis under conditions that ROS generation is limited (19, 20). Thus, its anti-apoptotic function is not limited to the antioxidant property. Nonetheless, this apparent antioxidant property of Bcl-2 has not been explained.

When human myeloid leukemia HL 60 and U-937 cells undergo apoptosis induced by staurosporine (21), etoposide (21), cytosine beta -D-arabinofuranoside (22), and ionizing radiation (23), there is an early release of cyt c from mitochondria, and the released cyt c participates in the activation of caspase 3. Bcl-2 family proteins prevent cyt c from entering the cytosol either by blocking cyt c release (21, 22) or by binding directly with cyt c (23). Cyt c is localized in the mitochondrial intermembrane space and is part of the mitochondrial electron transport chain. A variety of mitochondrial poisons are well known to stimulate ROS generation by a mechanism that involves inhibition of electron transfer, accumulation of reducing equivalents in the middle portion of the electron transfer chain, and direct one-electron transfer to O2 to produce superoxide (for review, see Ref. 24). This switch appears to occur principally at the level of coenzyme Q (ubiquinone/ubiquinol) and thus could also occur as a consequence of cyt c loss.

In this study, we used staurosporine-treated HL 60 cells to study the mechanism of ROS generation during apoptosis. Results show that the cellular redox change occurred following mitochondrial release of cytochrome c and was in parallel to the caspase activation. The release of cytochrome c was associated with inhibited mitochondrial respiration and stimulated mitochondrial superoxide production, and overexpression of Bcl-2 inhibited all of these processes.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results & Discussion
References

Cell Culture-- HL 60 cells transfected with bcl-2 (bcl-2) or vector alone (neo) were cultured as described (21). Overexpression of Bcl-2 was monitored by Western blot. Cells were passaged every 2-3 days and seeded at 0.25 × 106/ml, and apoptosis was induced by adding 1 µM staurosporine.

Measurement of Intracellular and Mitochondrial Redox Change-- After treatment, cells were pelleted and resuspended in 5% perchloric acid/saturated boric acid, supplemented with 5 µM gamma -glutamylglutamate as internal standard. Intracellular GSH and GSSG were measured with high pressure liquid chromatography as described (25), and the amount of acid-insoluble protein was measured by the Bradford method. Cell volume and pH were measured radiochemically (26), and the redox potential was calculated using the Nernst equation with E0 adjusted to cell pH (-59 mV/pH unit). E0 at pH 7.0 was taken as -240 mV (27). Mitochondrial GSH and GSSG were measured similarly, except cells were first permeabilized with digitonin as described below.

Measurement of Mitochondrial Generation of ROS-- After treatment with 1 µM staurosporine for 4 h, cells were stained with 15 µM dihydrorhodamine (DHR) for 20 min, washed with phosphate-buffered saline, and loaded onto a Becton-Dickinson FACStation. FL-1 fluorescence was recorded, and cell debris was electronically gated out based on the forward light scatter. 300 µM tert-butylhydroperoxide treatment was used as a positive control. The DHR fluorescence was also recorded with confocal microscopy. Cells double-stained with 60 nM DiOC6 and 15 µM DHR were washed and resuspended in 15 µl of phosphate-buffered saline and placed on a no. 1 thickness coverslip. The green and red fluorescence were simultaneously recorded with a Bio-Rad MRC 1024 laser scanning confocal microscopy system, with the excitation wavelength set at 488 nm. Images were acquired and processed with Laser-Sharp software, using identical background and gain settings. Six to eight areas were randomly picked, and representative ones are presented in Fig. 2.

Measurement of Mitochondrial Membrane Potential (mtDelta psi )-- After treatment, cells were loaded with either 2 µM rhodamine 123 (28) or 60 nM DiOC6 (29) for 10 min, and mtDelta psi was measured by FACScan.

Measurement of Substrate-stimulated Oxygen Consumption-- After treatment with staurosporine for the indicated periods of time, 2 × 106 cells were washed with phosphate-buffered saline and resuspended in mitochondrial respiration buffer (30). O2 consumption was measured in a 2.0-ml chamber with a Clark-type oxygen electrode (Yellow Springs) calibrated with air and sodium dithionite (30). Cells were permeabilized with 0.01 mg/ml digitonin for 1 min, and substrate-stimulated respiration was recorded by adding 2.5 mM succinate and 0.25 mM ADP. The substrate stimulated O2 consumption rate over the rate after digitonin permeabilization was calculated as the respiratory control ratio.

Measurement of Superoxide Generation in Isolated Mitochondria-- Mitochondria were isolated from neo and bcl-2 cells with nagarse-digitonin treatment (31). Measurements were performed in a SLM/Aminco DW-2000 spectrophotometer at 30 °C. 40 µM acetylated cytochrome c was included in the incubation buffer, and the absorbance change was monitored at 550 nm (32). Reaction was initiated by adding 3 mM succinate. KCN (0.5 mM) was used to inhibit normal electron flow and stimulate superoxide production (positive control), and bovine erythrocyte superoxide dismutase (SOD) (Sigma; 100 units) was added to verify that the reduction of acetylated cyt c was due to superoxide generation.

Western Blot Analysis of Mitochondrial cyt c Release-- Mitochondrial and cytosolic fractions were prepared with digitonin-nagarse treatment. Each lane was loaded with 50 µg of protein, and Western blot was performed as described (21), using a gift antibody from Dr. R. Jemmerson (University of Minnesota).

    RESULTS AND DISCUSSION
Top
Abstract
Introduction
Procedures
Results & Discussion
References

To determine whether an oxidant signal precedes or follows mitochondrial release of cyt c, we measured the redox state of the intracellular GSH pool as a function of time following treatment of neo cells with 1 µM staurosporine (Fig. 1). Under these conditions, cyt c release was detectable already at 1 h (Fig. 1B), but oxidation of cellular GSH/GSSG did not occur until after 2 h (Fig. 1A). By 6 h, the redox potential Eh was oxidized by 72 mV (from -239 ± 6 to -167 ± 9 mV), a change similar to the 86 mV oxidation in apoptotic HT29 cells (data not shown). In cells overexpressing Bcl-2, cyt c release was blocked (Fig. 1B), and the redox change was inhibited (Fig. 1A). The measured mitochondrial GSH/GSSG ratio changed with a similar time course (Fig. 1A, inset). Thus, cyt c loss preceded the generation of an oxidant signal and as previously reported, Bcl-2 blocked cyt c release (21) and had an apparent antioxidant function (17, 18), as measured by Eh of the GSH/GSSG pool and the mitochondrial GSH/GSSG ratio.


View larger version (44K):
[in this window]
[in a new window]
 
Fig. 1.   Time course of oxidation of cellular GSH/GSSG redox potential. A, human myeloid leukemia cells (HL 60) overexpressing Bcl-2 protein (bcl-2) and vector control (neo) were treated with 1 µM staurosporine for up to 6 h. Eh was calculated using the Nernst equation with E0 adjusted to cell pH. (*, p < 0.01, one-way analysis of variance). The measured GSH and GSSG values of control neo cells are 144 ± 10 and 2.7 ± 0.4 nmol/mg protein, respectively. Inset, time course of mitochondrial GSH/GSSG change. The measured GSH and GSSG values of permeabilized control neo cells are 12 ± 4 and 0.8 ± 0.3 nmol/mg protein, respectively. B, Western blot of mitochondrial cyt c release. C, time course of staurosporine-induced DNA fragmentation. neo (without and with 5 mM NAC) and bcl-2 cells were treated with 1 µM staurosporine. Genomic DNA was isolated, run on a 1% agarose gel, and visualized by ethidium bromide staining. Results are representative ones from three separate experiments.

Antioxidants, such as NAC, can inhibit apoptosis in some systems (12). Although the staurosporine-induced caspase activation and subsequent DNA fragmentation could be completely inhibited by overexpression of Bcl-2, they were not sensitive to NAC (Fig. 1C). Thus in staurosporine-induced apo-ptosis, the caspase activation seems to be redox-insensitive, and the effects of Bcl-2 cannot be attributed to its apparent antioxidant function.

Because the redox signal was not observed until after cyt c release, we then examined whether the mitochondrion is a possible source of the redox signal. For this, we used DHR, a non-fluorescent compound that accumulates in the mitochondria and can be oxidized to the fluorescent rhodamine (33). FACScan showed that DHR was oxidized in staurosporine-treated neo cells but not in cells overexpressing Bcl-2 (Fig. 2, A and B). Confocal microscopy confirmed that this fluorescence was mainly localized to the mitochondria, together with the mtDelta psi -driven dye DiOC6 (Fig. 2C). Thus, the results suggest that ROS may be generated in the mitochondria upon cyt c release and that this is prevented by Bcl-2 in association with its inhibition of cyt c release.


View larger version (51K):
[in this window]
[in a new window]
 
Fig. 2.   Generation of ROS in staurosporine-treated HL 60 cells as measured by DHR oxidation. A and B, neo and bcl-2 cells were treated with 1 µM staurosporine for 4 h and were stained with 15 µM DHR for 20 min. DHR fluorescence was measured by FACScan. C, control; +s, with 1 µM staurosporine; +t, with 300 µM tert-butylhydroperoxide (positive control). C, confocal microscopy of neo cells double stained with 5 µM DHR and 60 nM DiOC6, before and after staurosporine treatment. Results are representative ones from five separate experiments.

Babior and co-workers (30, 34) found that substrate-dependent mitochondrial O2 consumption was inhibited with loss of cyt c in a Fas-activated model of apoptosis. Measurements in mitochondria of neo cells treated with staurosporine also showed that substrate-stimulated O2 consumption was inhibited (Fig. 3A). Thus, the loss of cyt c is associated with an interruption of normal electron flow that could divert electron transfer to the generation of superoxide.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 3.   Mitochondrial functional change as a consequence of staurosporine treatment. A, substrate-stimulated respiration in 1 µM stauroporine-treated neo and bcl-2 cells (*, p < 0.05, one-way analysis of variance). B and C, FACScan of mtDelta psi  with two different mitochondrial membrane potential probes (rhodamine 123 and DiOC6) in neo cells treated with 1 µM staurosporine. Results are representative ones from five separate experiments.

Activation of the mitochondrial permeability transition (MPT) is a major controlling mechanism in some apoptotic systems (for review, see Ref. 35), and this could also contribute to cyt c release (data not shown) and superoxide production (36, 37). To determine whether the MPT had occurred in neo cells treated with staurosporine, we used FACS analysis with rhodamine 123 or DiOC6. Results showed that Delta psi was largely retained under conditions where cyt c was released and the redox signal was generated (Fig. 3, B and C). At later times, the Delta psi was lost (Ref. 21 and data not shown), indicating that the redox change preceded the MPT and was not a result of MPT.

To determine whether mitochondria that have lost cyt c during apoptotic signaling have increased substrate-dependent superoxide production, we measured stimulated superoxide production in mitochondria isolated from staurosporine-treated cells. Results showed that superoxide generation was enhanced in mitochondria isolated from staurosporine-treated neo cells. By 4 h, the rate was 5.28 ± 0.33 nmol/mg protein per min (Fig. 4A). This was dependent upon respiratory substrate and was inhibited by superoxide dismutase.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 4.   Measurement of superoxide generation in isolated mitochondria from neo (A) and bcl-2 (B) cells. Mitochondria were isolated with digitonin-nagarse treatment. Measurements were performed in a SLM/Aminco DW-2000 spectrophotometer at 30 °C as described under "Experimental Procedures." SOD, treated with 1 µM staurosporine for 4 h and with 100 units of bovine erythrocyte SOD in the reaction buffer. Results are representative ones from four separate experiments.

To determine whether superoxide production could be blocked by preventing cytochrome c release, superoxide production by mitochondria from staurosporine-treated bcl-2 cells was measured. Results showed that mitochondria from cells overexpressing Bcl-2 had no increase in superoxide production following staurosporine treatment (Fig. 4B). Addition of cyanide, a direct mitochondrial electron transport inhibitor, resulted in superoxide generation in mitochondria from Bcl-2-overexpressing cells at a rate similar to that from neo cells. Thus, the results show that the effect of Bcl-2 was not due to a direct electron-scavenging or superoxide-metabolizing activity of Bcl-2 itself but rather to the prevention of Obardot 2 production.

These observations demonstrate that the antioxidant activity of Bcl-2 is indirect and clarify an important issue concerning Bcl-2 function. However, this finding also raises a fundamental question about the redox signaling in cells. The redox state of the GSH/GSSG pool is substantially oxidized (-239 mV) compared with the NADPH pool (-394 mV) (38) that drives GSSG reduction. If the steady state Eh of GSH/GSSG reflects a balance between the rate of GSH oxidation by mitochondrially derived oxidants (e.g. superoxide and H2O2) and the rate of GSSG reduction by NADPH, then it places Bcl-2 at a pivotal point in regulation of the cellular thiol disulfide redox state by controlling the rate of mitochondrial generation of ROS (Fig. 5).


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 5.   Hypothetical reaction scheme for Bcl-2-dependent control of the cellular thiol-disulfide redox state. The GSH/GSSG redox state represents a kinetic balance between the rates of GSH oxidation (GPx-GSH peroxidase) and GSSG reduction (GRx-GSSG reductase). The balance of electron flow through cytochrome oxidase to produce H2O compared with transfer to O2 to generate Obardot 2 is controlled by the cytochrome c content in the intermembrane space. By controlling cyt c loss from mitochondria, Bcl-2 can alter the cytosolic GSH/GSSG redox state.

The present demonstration of a mechanism for ROS generation during apoptosis does not resolve whether ROS has a role in apoptosis signaling. Despite the fact that an oxidant signal occurs during apoptosis by diverse stimuli, so far the available pieces of evidence suggest that caspase activation is irrelevant to the redox state. In vitro data using cell-free systems indicated that caspase 3 activation was independent of the redox state of cyt c (39, 40). Similarly, when we added 5 mM NAC to the neo cells, we obtained no inhibition of caspase activation, as measured by DNA fragmentation (Fig. 1C) and phosphatidylserine translocation (data not shown). Thus when ROS is generated concomitantly with a direct activating mechanism of caspases, it might be only a side effect that is unrelated to the key signaling events leading to the caspase-executed cell death.

However, a range of other possible functions for ROS could exist beyond the activation of death proteases. Caspases are inhibited by oxidants (41, 42). The superoxide generated could function as a mechanism to inactivate caspases and prevent their destruction of cells that phagocytose apoptotic bodies (41). ROS may also counteract the lethal effects of caspases in non-apoptotic cells. Caspase 3 has recently been found to function in the processing of pro-interleukin 16, a non-apoptotic function that would appear to require some low level of constitutive activation (43). If low levels of cyt c release are involved in this process, a concomitant superoxide signal may activate protective mechanisms, such as the activation of the redox-sensitive transcription factor NF-kappa B (44, 45). In TNF-alpha -induced apoptosis, NF-kappa B has been shown to control the expression of several protective genes, such as c-IAP2 and MnSOD (13, 14). Despite the phosphorylation of I-kappa B, the intracellular redox state is known to be another regulatory mechanism of NF-kappa B (46).

Alternatively, the switch of mitochondrial electron transport from its normal pathway through cyt c, which does not result in free radical production, to one in which electrons are transferred to O2 with production of superoxide, may provide a fail-safe mechanism that complements cyt c-dependent caspase activation for the execution of cell death. The dramatic 75-mV oxidation of the cellular GSH/GSSG pool (Fig. 1A) is a sufficient signal to result in a 500-fold change in the function of systems regulated by vicinal dithiols with Eo in an appropriate range (47). Thus, global oxidation due to the electron transfer switch triggered by cyt c release could provide a general backup mechanism for a redox-activated molecular machinery of apoptosis. One example of such a mechanism could be the activation of MPT. The MPT pore has critical thiols, which upon oxidation can trigger its opening (48) and release the apoptosis-inducing factor (35, 49). Although not purified yet, apoptosis-inducing factor seems also to be a cysteine protease and can induce nuclear apoptosis in cell-free systems. Oxidants, such as diamide and tert-butylhydroperoxide, can induce its release from isolated mitochondria (49). The time course of mtDelta psi change (Fig. 3) indicated that MPT does not contribute significantly to the generation of superoxide in staurosporine-induced apoptosis in HL 60 cells, but rather superoxide production may subsequently activate the MPT in a final common pathway of cell death.

    ACKNOWLEDGEMENTS

We thank Prof. Sten Orrenius for critical reading and helpful comments; Dr. Ronald Jemmerson (University of Minnesota) for kindly providing the anti-cytochrome c antibody; Nyoka Roberts for manuscript preparation; and Dr. Jie Yang and Kasey Nelson for technical support.

    FOOTNOTES

* This work was supported by National Institutes of Health Grants ES 09047 and EY 07892.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 404-727-5970; Fax: 404-727-3231; E-mail: dpjones{at}emory.edu.

1 The abbreviations used are: ROS, reactive oxygen species; cyt c, cytochrome c; SOD, superoxide dismutase; NAC, N-acetylcysteine; TNF, tumor necrosis factor; MnSOD, manganese superoxide dismutase; DHR, dihydrorhodamine; Eh, GSH redox potential; MPT, mitochondrial permeability transition.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results & Discussion
References

  1. Gardner, A. M., Xu, F. H., Fady, C., Jacoby, F. J., Duffey, D. C., Tu, Y., and Lichtenstein, A. (1997) Free Radical Biol. Med. 22, 73-83[CrossRef][Medline] [Order article via Infotrieve]
  2. Sato, N., Iwata, S., Nakamura, K., Hori, T., Mori, K., and Yodoi, J. (1995) J. Immunol. 154, 3194-3203[Abstract/Free Full Text]
  3. Bustamante, J., Tovar, B. A., Montero, G., and Boveris, A. (1997) Arch. Biochem. Biophys. 337, 121-128[CrossRef][Medline] [Order article via Infotrieve]
  4. Sun, X., and Ross, D. (1996) Chem. Biol. Interact. 100, 267-276[CrossRef][Medline] [Order article via Infotrieve]
  5. Albrecht, H., Tschopp, J., and Jongeneel, C. V. (1994) FEBS. Lett. 351, 45-48[CrossRef][Medline] [Order article via Infotrieve]
  6. Wang, J. H., Redmond, H. P., Watson, R. W., and Bouchier-Hayes, D. (1997) Am. J. Physiol. 272, C1543-C1551[Abstract/Free Full Text]
  7. Garcia-Ruiz, C., Colell, A., Mari, M., Morales, A., and Fernandez-Checa, J. C. (1997) J. Biol. Chem. 272, 11369-11377[Abstract/Free Full Text]
  8. Atabay, C., Cagnoli, C. M., Kharlamov, E., Ikonomovic, M. D., and Nanev, H. (1996) J. Neurosci. Res. 43, 465-475[CrossRef][Medline] [Order article via Infotrieve]
  9. Dobmeyer, T. S., Findhammer, S., Dobmeyer, J. M., Klein, S. A., Raffel, B., Hoelzer, D., Helm, E. B., Kabelitz, D., and Rossol, R. (1997) Free Radical Biol. Med. 22, 775-785[CrossRef][Medline] [Order article via Infotrieve]
  10. Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., and Voglestein, B. (1997) Nature 389, 300-305[CrossRef][Medline] [Order article via Infotrieve]
  11. Johnson, T. M., Yu, Z. X., Ferrans, V. J., Lowenstein, R. A., and Finkel, T. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 11848-11852[Abstract/Free Full Text]
  12. Mayer, M., and Noble, M. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 7496-7500[Abstract]
  13. Iwata, S., Hori, T., Sata, N., Hirota, K., Sasada, T., Mitsui, A., Hirakawa, T., and Yodoi, J. (1997) J. Immunol. 158, 3108-3117[Abstract]
  14. Wong, G. H., Elwell, J. H., Oberley, L. W., and Goeddel, D. V. (1989) Cell 58, 923-931[Medline] [Order article via Infotrieve]
  15. Chu, Z. L., McKinsey, T. A., Liu, L., Gentry, J. J., Malim, M. H., and Ballard, D. W. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 10057-10062[Abstract/Free Full Text]
  16. Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., and Verma, I. M. (1996) Science 274, 787-789[Abstract/Free Full Text]
  17. Hockenbery, D. M., Oltvai, Z. N., Yin, X. M., Milliiman, C. L., and Korsmeyer, S. J. (1993) Cell 75, 241-251[Medline] [Order article via Infotrieve]
  18. Kane, D. J., Sarafian, R., Anton, H., Butler, G. J., Selverstone, V. T., and Bredesen, D. E. (1993) Science 262, 1274-1277[Medline] [Order article via Infotrieve]
  19. Jacobson, M. D., Burne, J. F., King, M. P., Miyashita, T., Reed, J. C., and Raff, M. C. (1993) Nature 361, 365-369[CrossRef][Medline] [Order article via Infotrieve]
  20. Shimizu, S. Y., Eguchl, H., Kosaka, W., Kamiike, H., Masuda, H., and Tsujimoto, Y. (1995) Nature 374, 811-813[CrossRef][Medline] [Order article via Infotrieve]
  21. Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T-I., Jones, D. P., and Wang, X. (1997) Science 275, 1129-1132[Abstract/Free Full Text]
  22. Kim, C. N., Wang, X., Huang, Y., Ibrado, A. M., Liu, L., Fang, G., and Bhalla, K. (1997) Cancer Res. 57, 3115-3120[Abstract]
  23. Kharbanda, S., Pandey, P., Schefield, L., Israels, S., Roncinske, R., Yoshida, K., Bharti, A., Yuan, Z-M., Saxena, S., Weichselbaum, R., Nalin, C., and Kufe, D. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 6932-6942
  24. Turrens, J. F. (1997) Biosci. Rep. 17, 3-8[Medline] [Order article via Infotrieve]
  25. Jones, D. P., Maellaro, E., Jiang, S., Slater, A. F., and Orrenius, S. (1995) Immunol. Lett. 205, 45-51
  26. Andersson, B. S., Aw, T. Y., and Jones, D. P. (1987) Am. J. Physiol. 254, C349-C355
  27. Rost, J., and Rapoport, S. (1964) Nature 201, 185
  28. Lemaster, J. J., Nieminen, A. L., Chacon, E., Bond, J. M., Harper, I., Reece, J. M., and Herman, B. (1994) Methods Toxicol. 1B, 438-455
  29. Marchetti, P., Castedo, M., Susin, S. A., Zamzami, N., Hirsh, T., Macho, A., Haeffner, A., Hirsch, F., Geuskens, M., and Kroeamer, G. (1996) J. Exp. Med. 184, 1155-1160[Abstract]
  30. Krippner, A., Matsuno-Yagi, A., Gottlieb, R. A., and Babior, B. M. (1996) J. Biol. Chem. 271, 21629-21636[Abstract/Free Full Text]
  31. Lash, L. H., and Sall, J. M. (1993) Methods Toxicol. 2, 8-28
  32. Kakinuma, K., and Minakami, S. (1978) Biochim. Biophys. Acta 538, 50-59[Medline] [Order article via Infotrieve]
  33. Rothe, G., Emmendorffer, A., Oser, A., Roesler, J., and Valet, G. (1991) J. Immunol. Methods 138, 133-135[CrossRef][Medline] [Order article via Infotrieve]
  34. Adachi, S., Cross, A. R., Babior, B. M., and Gottlieb, R. A. (1997) J. Biol. Chem. 272, 21878-21882[Abstract/Free Full Text]
  35. Hrish, T., Marzo, I., and Kroemer, G. (1997) Biosci. Rep. 17, 67-76[Medline] [Order article via Infotrieve]
  36. Backway, K. L., McCulloch, E. A., Chow, S., and Hedley, D. W. (1997) Cancer Res. 57, 2446-2451[Abstract]
  37. Marchetti, P., Decaudin, D., Macho, A., Zamzami, N., Hirsch, T., Susin, S. A., and Kroemer, G. (1997) Eur. J. Immunol. 27, 289-296[Medline] [Order article via Infotrieve]
  38. Sies, H. (1982) in Metabolic Compartmentation (Sies, H., ed), pp. 205-231, Academic Press, London
  39. Kluck, R. M., Martin, S. J., Hoffman, B. M., Zhou, J. S., Green, D. R., and Newmeyer, D. D (1997) EMBO J. 16, 4639-4649[Abstract/Free Full Text]
  40. Hampton, M. B., Zhivotovsky, B., Slater, A. F. G., Burgess, D. H., and Orrenius, S. (1998) Biochem. J. 329, 95-99[Medline] [Order article via Infotrieve]
  41. Hampton, M. B., and Orrenius, S. (1997) FEBS. Lett. 414, 552-556[CrossRef][Medline] [Order article via Infotrieve]
  42. Nobel, C. S., Burgess, D. H., Zhivotovsky, B., Burkitt, M. J., Orrenius, S., and Slater, A. F. (1996) Chem. Res. Toxicol. 10, 636-643[CrossRef]
  43. Zhang, Y., Center, D. M., Wu, M. H., Cruikshank, W. W., Yuan, J., Andrews, D. W., and Kornfeld, H. (1998) J. Biol. Chem. 273, 1144-1149[Abstract/Free Full Text]
  44. Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., and Verma, I. M. (1996) Science 274, 787-789[Abstract/Free Full Text]
  45. Liu, Z.-G., Hsu, H., Goeddel, D. V., and Michael, K. (1996) Cell 87, 565-576[Medline] [Order article via Infotrieve]
  46. Staal, F. J., Roederer, M., Herzenberg, L. A., and Herzenberg, L. A. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 9943-9947[Abstract]
  47. Gilbert, H. F. (1990) Adv. Enzymol. Relat. Areas Mol. Biol. 63, 69-172[Medline] [Order article via Infotrieve]
  48. Zoratti, M., and Szabo, I. (1995) Biochim. Biophys. Acta 1241, 139-176[Medline] [Order article via Infotrieve]
  49. Susin, S. A., Zamzami, N., Castedo, M., Hirsh, T., Marchetti, P., Macho, A., Daugas, E., Geuskens, M., and Kroemer, G. (1996) J. Exp. Med. 184, 1331-1341[Abstract]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.